tiprankstipranks

Paul Geyer Insider Profile

109 Followers
Paul Geyer, Director at Eupraxia Pharmaceuticals, holds 374.07K shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX), holds 2.64M shares in TIMIA Capital (Ticker: TSE:MONT), holds 351.46K shares in Neovasc (Ticker: NVCN). Most recently, Paul Geyer Sold ― shares of Eupraxia Pharmaceuticals on Mar 19, 2026 for an estimated value of C$162.00K.
tipranks
Paul  Geyer

Paul Geyer
Eupraxia Pharmaceuticals (EPRX)
Director

Ranked #2,774 out of 108,921 Corporate Insiders

Profitable Transactions

50%
14 out of 28 Profitable Transactions

Average Return

+27.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$3M
99.40%
0.60%
A breakdown of Paul Geyer's holdings

Insider Roles

Eupraxia Pharmaceuticals
(EPRX)
Director
TIMIA Capital
(MONT)
Director
Roles that Paul Geyer holds in companies

Most Profitable Insider Trade

Stock:
Eupraxia Pharmaceuticals
(EPRX)
Rating:Informative Buy
Date:Apr 25, 2022 - Apr 25, 2023
Return:+306.60%
The most profitable trade made by Paul Geyer

Paul Geyer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eupraxia Pharmaceuticals
Mar 19, 2026
Director
Informative Sell
162.00K
C$4.35M
NVCN
Neovasc
Nov 24, 2022
Informative Buy
19.50K
$10.55M
TIMIA Capital
Mar 08, 2024
Director
Informative Buy
21.25K
C$26.39K
List of latest transactions for each holding click on a transaction to see Paul Geyer's performance on stock

Paul Geyer insider profile FAQ

What is the percentage of profitable transactions made by Paul Geyer?
The percentage of profitable transactions made by Paul Geyer is 50%.
    What is the average return per transaction made by Paul Geyer?
    The average return per transaction made by Paul Geyer is 27.20%.
      What stocks does Paul Geyer hold?
      Paul Geyer holds: TSE:EPRX, NVCN, TSE:MONT stocks.
        What was Paul Geyer’s latest transaction?
        Paul Geyer latest transaction was an Informative Sell of C$162.00K.
          What was Paul Geyer's most profitable transaction?
          Paul Geyer’s most profitable transaction was an Informative Buy of TSE:EPRX stock on April 25, 2022. The return on the trade was 306.60%.
            What is Paul Geyer's role in Eupraxia Pharmaceuticals?
            Paul Geyer's role in Eupraxia Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.